SOFWF (Sofwave Medical) Moat Score: 3/10 (As of Jul. 01, 2026)


SOFWF Sofwave Medical Ltd SOFWF
48 GF Score
Price $16.00
GF Value $9.78
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sofwave Medical Moat Score?

Sofwave Medical SOFWF 48 Moat Score is 3 as of Jul. 01, 2026. GuruFocus rates SOFWF with a GF Score™ of 48/100 and a GF Value™ of $9.78 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Sofwave Medical ranks better than 75.89% on this metric.

Sofwave Medical has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Sofwave Medical has No Moat: Sofwave Medical Ltd operates in the medical device industry with limited market share and lacks significant intellectual property or regulatory barriers. The company faces strong competition and has no substantial cost advantages, resulting in a very weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Sofwave Medical might have No Moat - Very weak/transient advantages.

Sofwave Medical  (OTCPK:SOFWF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Sofwave Medical Moat Score Related Terms

SOFWF vs ABT, SYK, MDT: Moat Score Comparison

For the Medical Devices subindustry, Sofwave Medical's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sofwave Medical Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's Moat Score distribution charts can be found below:

* The bar in red indicates where Sofwave Medical's Moat Score falls into.


SOFWF
48GF Score
Sofwave Medical Ltd SOFWF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Sofwave Medical (SOFWF) has a Moat Score of 3 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Sofwave Medical ranks #204 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is Sofwave Medical's Moat Score too high?
Sofwave Medical's current Moat Score is 3. Based on the distribution chart, Sofwave Medical ranks #204 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sofwave Medical has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's Moat Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sofwave Medical ranks #204 out of 846 companies for Moat Score. This places Sofwave Medical in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Sofwave Medical's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.78, compared to a current price of $16.00 — trading 63.6% above its estimated fair value. The current Moat Score is 3. Sofwave Medical's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current Moat Score is 3 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sofwave Medical (SOFWF) Overvalued in 2026?

Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued. The current stock price of $16.00 is trading 63.6% above its estimated GF Value™ of $9.78. GuruFocus considers Sofwave Medical to be Significantly Overvalued.

Key valuation signals for SOFWF:

  • Moat Score: 3
  • GF Value™: $9.78 vs. price of $16.00 (63.6% above fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sofwave Medical Business Description

Other Exchanges SOFW:Israel
Address Oak Medtech, Tavor, Alon Medtech Venture, Yokneam Illit, ISR, 2069200
Sofwave Medical Ltd is engaged in the development, marketing, and production of non-invasive technology for skin rejuvenation and firming treatment.
48GF Score

Get the complete analysis for SOFWF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.00
Price
$9.78
GF Value